Furthermore, striatal dopamine release is modulated by sex hormones such as estradiol and progesterone; further, vesicular monoamine transporter 2 (VMAT2) protein expression, a therapeutic target in TS treatment, is also regulated by estradiol [90]. This evidence concerns the gene SLC18A2 and Timothy syndrome.